We are live on
!
Find out more
SM
SG3 Management Portfolio holdings
AUM
$6.45K
1-Year Est. Return
61.81%
This Fund
S&P 500
This Quarter
Est. Return
+9.09%
1 Year Est. Return
-61.81%
3 Year Est. Return
-38.3%
5 Year Est. Return
-6.2%
10 Year Est. Return
–
AUM
$4B
AUM Growth
-$1.25B
(-24%)
Cap. Flow
-$1.28B
Cap. Flow
% of AUM
-32.02%
Top 10 Holdings %
Top 10 Hldgs %
20.82%
Holding
1,612
New
626
Increased
195
Reduced
208
Closed
487
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Jazz Pharmaceuticals
JAZZ
|
+$10.2M |
| 2 |
PARA
Paramount Global Class B
PARA
|
+$6.08M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$5.95M |
| 4 |
Biogen
BIIB
|
+$5.94M |
| 5 |
Aon
AON
|
+$5.61M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$294M |
| 2 |
Lennar Class A
LEN
|
+$76.3M |
| 3 |
RH
RH
|
+$25.1M |
| 4 |
ARK Genomic Revolution ETF
ARKG
|
+$22.5M |
| 5 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$22.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 1.79% |
| 2 | Communication Services | 1.57% |
| 3 | Technology | 1.13% |
| 4 | Consumer Discretionary | 1.05% |
| 5 | Financials | 0.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
PUT
General Motors
GM
$80.9B
| $747K | 0.02% |
13,000
-57,000
| -81% | -$3.03M |
|
677
CALL
United Natural Foods
UNFI
$3.04B
| $741K | 0.02% |
+22,500
| New | +$627K |
|
678
CALL
Enanta Pharmaceuticals
ENTA
$362M
| $740K | 0.02% |
+15,000
| New | +$748K |
|
|
CCXI
679
PUT
DELISTED
ChemoCentryx, Inc.
CCXI
| $738K | 0.02% |
14,400
-15,600
| -52% | -$939K |
|
680
PUT
XPeng
XPEV
$12.5B
| $730K | 0.02% |
20,000
-30,000
| -60% | -$1.25M |
|
681
PUT
iShares Global Clean Energy ETF
ICLN
$2.22B
| $729K | 0.02% |
+30,000
| New | +$839K |
|
682
CALL
Rigel Pharmaceuticals
RIGL
$723M
| $729K | 0.02% |
21,330
+16,180
| +314% | +$641K |
|
|
TTM
683
PUT
DELISTED
Tata Motors Limited
TTM
| $728K | 0.02% |
+35,000
| New | +$705K |
|
684
PUT
Standard BioTools
LAB
$342M
| $723K | 0.02% |
+160,000
| New | +$879K |
|
685
CALL
Corcept Therapeutics
CORT
$9.98B
| $714K | 0.02% |
30,000
+12,500
| +71% | +$334K |
|
686
Vodafone
VOD
$37.1B
| $713K | 0.02% |
38,700
+23,700
| +158% | +$428K |
|
687
CALL
JetBlue
JBLU
$2.16B
| $712K | 0.02% |
35,000
+5,000
| +17% | +$86.7K |
|
|
HES
688
CALL
DELISTED
Hess
HES
| $708K | 0.02% |
+10,000
| New | +$639K |
|
689
American Express
AXP
$224B
| $707K | 0.02% |
+5,000
| New | +$661K |
|
|
CVET
690
PUT
DELISTED
Covetrus, Inc. Common Stock
CVET
| $704K | 0.02% |
+23,500
| New | +$801K |
|
|
COWN
691
DELISTED
Cowen Inc. Class A Common Stock
COWN
| $703K | 0.02% |
+20,000
| New | +$644K |
|
692
CALL
Packaging Corp of America
PKG
$22.2B
| $699K | 0.02% |
+5,200
| New | +$709K |
|
693
PUT
Unilever
UL
$142B
| $698K | 0.02% |
+11,111
| New | +$708K |
|
694
CALL
Milestone Pharmaceuticals
MIST
$129M
| $695K | 0.02% |
+120,000
| New | +$878K |
|
|
TVRD
695
Tvardi Therapeutics
TVRD
$20.1M
| $695K | 0.02% |
+889
| New | +$609K |
|
696
CALL
TMC The Metals Company
TMC
$1.49B
| $692K | 0.02% |
+69,700
| New | +$757K |
|
697
CALL
Exelixis
EXEL
$13.9B
| $678K | 0.02% |
30,000
+15,000
| +100% | +$339K |
|
|
698
PUT
Exelixis
EXEL
$13.9B
| $678K | 0.02% |
30,000
+15,000
| +100% | +$339K |
|
699
PUT
Bloom Energy
BE
$48.2B
| $676K | 0.02% |
25,000
+18,400
| +279% | +$600K |
|
700
3M
MMM
$91.8B
| $674K | 0.02% |
+4,186
| New | +$627K |
|
Similar funds
EAM
CAM
CCM
GPCM
MAM
BGCI
TPL
RC
SG3 Management's Q1 2021 Portfolio in Review
As of Q1 2021, SG3 Management held 1,612 positions worth $4B, down 24% from $5.25B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
SG3 Management withdrew a net $1.28B in Q1 2021, closing 487 positions and reducing 208 holdings. Its most notable exit was Amazon, an estimated $294M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 1.8% of assets, up from 0.67% a quarter earlier, followed by Communication Services and Technology.
Against the trend, SG3 Management opened a new position in Albemarle worth $4.16M.
- SG3 Management's largest Q1 2021 buy was Albemarle: 28,500 shares worth $4.16M.
- SG3 Management added most to Jazz Pharmaceuticals in Q1 2021, an estimated $10.2M increase.
- SG3 Management's biggest Q1 2021 reduction was RH, cutting an estimated $25.1M.
- SG3 Management fully exited Amazon in Q1 2021, selling an estimated $294M.
- SG3 Management's ten largest holdings make up 21% of its $4B portfolio in Q1 2021.
- SG3 Management opened 626 new positions and closed 487 in Q1 2021.
- SG3 Management's portfolio value fell 24% quarter-over-quarter to $4B.
Based on SG3 Management's 13F filing for Q1 2021, filed 17 May 2021.